Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings

ESMO Virtual Plenary with AACR Expert Commentary: February 2024

ESMO-Virtual-Plenary-February-2024-1000x250-AACR-date
Start date
15 Feb 2024
End date
16 Feb 2024
Location
Virtual Meeting

RATIONALE-315: Event-free survival (EFS) and overall survival (OS) of neoadjuvant tislelizumab (TIS) plus chemotherapy (CT) with adjuvant TIS in resectable non-small cell lung cancer (NSCLC)

Thursday, 15 February 2024

Friday, 16 February 2024

18:30-19:30 CET

13:00-14:10 CET

Welcome and introduction, Scientific background and context
Marina Garassino, University of Chicago, Chicago, IL, USA

RATIONALE-315: Event-free survival (EFS) and overall survival (OS) of neoadjuvant tislelizumab (TIS) plus chemotherapy (CT) with adjuvant TIS in resectable non-small cell lung cancer (NSCLC)
Dongsheng Yue, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 

Critical analysis and perspectives
Luis Paz-Ares, University Hospital 12 de Octubre, Madrid, Spain

AACR Expert Commentary
Justin Gainor, MGH - Massachusetts General Hospital, Boston, MA, USA

Discussion and Q&A (i)
Faculty and online audience

Virtual Plenary Expert Insights: Webcast of 15 February presentations, Discussion and Q&A (ii)
Faculty and online audience

Chair: Ross Soo, NCIS - National University Cancer Institute Singapore, Singapore

Dongsheng Yue, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 

Luis Paz-Ares, University Hospital 12 de Octubre, Madrid, Spain

Adlinda Alip, University Malaya, Kuala Lumpur, Malaysia

Rainbow Lau, The Chinese University of Hong Kong - Prince of Wales Hospital, Hong Kong, China

James C-H Yang, NTUCC - National Taiwan University Cancer Center, Taipei, Taiwan

Meeting resources

Slides and webcasts from ESMO Virtual Plenaries are open to all ESMO Account holders, according to the presenters' agreement to release them.

Login and Watch now!

See all resources

How to Access

The ESMO Virtual Plenaries are available to all healthcare professionals working in oncology.

No registration is required to participate. However, you will need to log in with your ESMO membership or free ESMO Account to watch the presentation. Access to the ESMO Virtual Plenary will be open 30 min before the session starts.

Don't have an ESMO account?

Please set up your ESMO Account now to access the ESMO Virtual Plenary.

You may also be interested in...

ESMO Virtual Plenaries

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.